• Teva secures FDA approval for migraine drug Ajovy pharmaceutical-technology
    September 20, 2018
    The US Food and Drug Administration (FDA) has granted approval to Teva Pharmaceutical Industries’ Ajovy (fremanezumab-vfrm) injection for the preventive treatment of migraine in adults.
PharmaSources Customer Service